Global Medical Aid

India's G20 Presidency Drives Global Digital Health Initiative for Accessible and Equitable Global Healthcare

Retrieved on: 
Thursday, August 17, 2023
Vaccine, Traditional medicine, Joint FAO/WHO Expert Committee on Food Additives, Therapy, Fertilizer, Global Initiative, Ministry of Ayush, TB, INB, Initiative, Medicine, Research, UNICEF, DPG Media, Ministry, AYUSH, Canada–United States Consultative Committee on Agriculture, Digital health, Acceleration, Innovation, Global North and Global South, G20, Growth, Digital, Global Medical Aid, WHO, ADG, Chemical substance, Ministry of Health and Family Welfare, Mobile phone, Medical device, Nursing, Pharmaceutical industry, Renewable energy, Health, Envelope (music)

The prestigious gathering promises impactful discussions on global health collaboration and the launch of a Global Initiative on Digital Health.

Key Points: 
  • The prestigious gathering promises impactful discussions on global health collaboration and the launch of a Global Initiative on Digital Health.
  • Embarking on a Digital Healthcare era: The Global Initiative on Digital Health launches on 19 August 2023.
  • The G20 Health Minister's Meeting focuses around three primary concerns outlined in the G20 Health Track.
  • Fostering global collaborations - Advantage Health Care India 2023: The G20 India Presidency casts a prominent spotlight on global collaborations through the 'Advantage Health Care India 2023' event.

India's G20 Presidency Drives Global Digital Health Initiative for Accessible and Equitable Global Healthcare

Retrieved on: 
Thursday, August 17, 2023
Traditional medicine, Joint FAO/WHO Expert Committee on Food Additives, Fertilizer, Ministry of Ayush, INB, Initiative, Medicine, Research, Multimedia, UNICEF, DPG Media, Ministry, AYUSH, Canada–United States Consultative Committee on Agriculture, Digital health, Acceleration, Innovation, Global North and Global South, G20, Global Medical Aid, Envelope (music), Growth, Digital, WHO, ADG, Therapy, Vaccine, Chemical substance, Ministry of Health and Family Welfare, Mobile phone, Medical device, Renewable energy, Diagnosis, Health

The prestigious gathering promises impactful discussions on global health collaboration and the launch of Global Initiative on Digital Health.

Key Points: 
  • The prestigious gathering promises impactful discussions on global health collaboration and the launch of Global Initiative on Digital Health.
  • Embarking on a Digital Healthcare Era: Global Initiative on Digital Health Launches August 19, 2023.
  • The G20 Health Minister's Meeting will focuse around three primary concerns outlined in the G20 Health Track.
  • Fostering Global Collaborations: Advantage Health Care India 2023: The G20 India Presidency casts a prominent spotlight on global collaborations through the 'Advantage Health Care India 2023' event.

Henry Schein Reports Solid Second-Quarter 2023 Financial Results and Affirms Full-year Guidance

Retrieved on: 
Monday, August 7, 2023
Managed Care, Medical Supplies, Health, Medical Devices, Hospitals, Supply Chain Management, Dental, Retail, Uncertainty, Global Dental Relief, COVID-19, GAAP, Public expenditure, Acquisition, PPE, Investment, SSA Global Technologies, Growth, Global Medical Aid, EPS, Total, Pharmaceutical industry, Bank, Cryptocurrency

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the second quarter ended July 1, 2023.

Key Points: 
  • Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the second quarter ended July 1, 2023.
  • “Our outlook reflects overall confidence in our business and in the markets we serve.”
    Mr. Bergman continued, “Our financial results and guidance demonstrate the continued advancement of our 2022-2024 BOLD+1 Strategic Plan.
  • The Company is not providing a reconciliation of its 2023 non-GAAP guidance to its projected 2023 diluted EPS prepared on a GAAP basis.
  • The Company will hold a conference call to discuss second-quarter 2023 financial results today, beginning at 10:00 a.m. Eastern time.

Wellbeing Solutions Leader Workplace Options Hosts Global Burnout Conference

Retrieved on: 
Wednesday, June 21, 2023
Presenteeism, Burnout, Occupational safety and health, Human resources, International, Workflow, Culture, Workplace, Employment, OSHA, Organization, SVP Worldwide, European, Acadia University, International SOS, WPO, Global Medical Aid, Management, Health, Willamette University, SVP, Conference, Create, World Health Organization, Nursing

RALEIGH, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Workplace Options (WPO), the largest independent provider of holistic wellbeing solutions, hosted a global virtual conference: Navigating Burnout to Create Resilient Work Environments to demonstrate WPO’s leadership in empowering employers to create healthy workplaces where employees thrive.

Key Points: 
  • RALEIGH, N.C., June 21, 2023 (GLOBE NEWSWIRE) -- Workplace Options (WPO), the largest independent provider of holistic wellbeing solutions, hosted a global virtual conference: Navigating Burnout to Create Resilient Work Environments to demonstrate WPO’s leadership in empowering employers to create healthy workplaces where employees thrive.
  • Identifying chronic situational stressors on the job is key to eliminating burnout and improving the psychological safety of an organization.
  • WPO understands such challenges and delivers customized solutions on a global scale,” said Alan King, WPO President and CEO.
  • He reiterated that managers must focus on “fixing the workplace rather than fixing the worker.” The most successful burnout interventions seek to improve workflow, teamwork, and leadership.

Work Health Solutions Names Dr. Peter Lee Chief Executive Officer

Retrieved on: 
Wednesday, June 14, 2023
Managed Care, Health, Telemedicine, Virtual Medicine, Other Health, University, General Electric, Intuition, American College of Occupational and Environmental Medicine, Boston Medical Center, Chapel Hill, Employment, Global health, Multimedia, Preventive healthcare, University of North Carolina at Pembroke, Africa/Harvard School of Public Health Partnership for Cohort Research and Training, Occupational Safety and Health Act 1994, Public health, Medical director, MD, Robert Larner College of Medicine, Global Medical Aid, American College, Harvard School of Dental Medicine, Environmental medicine, Management, Amazon

Work Health Solutions, providers of concierge-style occupational medicine for large-scale employers nationwide, announces the appointment of Peter Lee, MD as Chief Executive Officer.

Key Points: 
  • Work Health Solutions, providers of concierge-style occupational medicine for large-scale employers nationwide, announces the appointment of Peter Lee, MD as Chief Executive Officer.
  • Most recently, Dr. Lee served as Global Medical Director for Amazon where he led clinical operations and industrial hygiene, directed occupational health and wellness, developed worldwide responsive health policies, and drove advancements in health technology, global health security and benefits design.
  • View the full release here: https://www.businesswire.com/news/home/20230614816100/en/
    Peter Lee, MD - Amazon’s Former Global Medical Director, now Chief Executive Officer of Work Health Solutions, providers of concierge-style occupational medicine for large-scale employers nationwide.
  • (Photo: Business Wire)
    “At Amazon, we enlisted Work Health Solutions as a strategic partner, and they exceeded every expectation with their unique approach and exceptional customer service.

RIT's Hope for Honduras initiative delivers custom neonatal ambulance

Retrieved on: 
Thursday, September 29, 2022
GMR, Parade, Love, RIT, Emergency, International Red Cross and Red Crescent Movement, Organization, Intention, Honduran Red Cross, Patient, Travel, Little Angels, Disease, Student, Technology, Friends, Transport, Rochester Institute of Technology, Bronco All Terrain Tracked Carrier, Hospital, Mortality, School, Global Medical Aid, Medicine, Management, Hope

ROCHESTER, N.Y., Sept. 29, 2022 /PRNewswire-PRWeb/ -- After five years of collaboration and production, the neonatal transport ambulance designed by RIT's Hope for Honduras team has hit the ground in Honduras. The ambulance will help save countless young lives by greatly enhancing medical access to neonatal care for those living in rural areas of the country.

Key Points: 
  • ROCHESTER, N.Y., Sept. 29, 2022 /PRNewswire-PRWeb/ -- After five years of collaboration and production, the neonatal transport ambulance designed by RIT's Hope for Honduras team has hit the ground in Honduras.
  • The ambulance is equipped with lifesaving medical equipment and is designed to travel both the roads and the terrain of Honduras.
  • She will travel to Honduras this month to help assemble the ambulance and train Red Cross and hospital staff on the new equipment.
  • For more information about the ambulance and overall initiative, go to RIT's Hope for Honduras webpage .

Vicore announces multiple scientific abstracts and presentations at upcoming conferences during the autumn

Retrieved on: 
Friday, August 19, 2022
Global Medical Aid, Keck School of Medicine of USC, Cardiology, AIR, N-terminal prohormone of brain natriuretic peptide, Mortality, IPF, ESC Congress, Untranslatability, European Society of Cardiology, Congress, European Respiratory Society, Plasma, COVID-19, II, Bleomycin, International Congress on Tuberculosis, Infection, University of Southern California, Lung, Hypertension, Idiopathic pulmonary fibrosis, University, Pharmaceutical industry, C21, Vicor Corporation

Plasma NT-proBNP is a predictive marker for severity and mortality in COVID-19 infections.

Key Points: 
  • Plasma NT-proBNP is a predictive marker for severity and mortality in COVID-19 infections.
  • Dr Raud will also participate in a panel discussion on "Novel In Vitro Models & Novel In Vivo Models Versus Bleomycin: Do They Better Represent IPF?".
  • The first poster is entitled "Interim results from AIR, an open-label, single arm, 36-week Ph 2 trial of C21 in subjects with idiopathic pulmonary fibrosis."
  • The second poster is entitled "Effects of oral angiotensin II type 2 receptor agonist C21 in Sugen-hypoxia-induced pulmonary fibrosis and hypertension."

Femasys To Host Key Opinion Leader Event on FemBloc, a First-of-its-Kind Medical Solution for Permanent Birth Control and an Important Option for Women Post Overturn of Roe v. Wade

Retrieved on: 
Wednesday, July 20, 2022
Ipas, Gynaecology, Anesthesia, World, Obstetrics and gynaecology, GLOBE, MPH, Organic, Population Services International, Stanford University Medical Center, Global Medical Aid, Birth, Woman, Special, Infertility, Research, Planned Parenthood, KOL, NASDAQ, World Health Organization, Cervical cancer, Roe v. Wade, Q&A, Ministry, Technology, Publication, Tubing (recreation), Pathfinder, Reproductive health, International, SPIRES, Hormone, Stanford University, Parenthood, Non-governmental organization, Republic, Medical device, Birth control, Obstetrics, MD, Health

Dr. Blumenthal has a distinguished career in Obstetrics & Gynecology spanning close to 40 years and has conducted advocacy work in Womens Health on a global basis.

Key Points: 
  • Dr. Blumenthal has a distinguished career in Obstetrics & Gynecology spanning close to 40 years and has conducted advocacy work in Womens Health on a global basis.
  • Femasys FemBloc, a novel approach to permanent birth control, will be discussed as an important potential medical solution as it pertains to womens contraceptive options and choices, especially given the recent overturning of Roe v. Wade.
  • Confirmation of procedure success can be achieved after 90 days, which would provide women with a certainty no other option can achieve.
  • Its two lead product candidates are FemBloc permanent birth control and FemaSeed localized directional insemination for infertility.

Medical Beds Market Size to Reach USD 5004.9 Million by 2028 at a CAGR of 2.5% | Valuates Reports

Retrieved on: 
Tuesday, July 12, 2022
People, Government budget balance, Hospital, Pregnancy, Medical device, Clothing, Patient, Review, Bed, Dementia, ICU, COVID-19, Time, Investment, Skin, Pressure, CAGR, Global Medical Aid, Growth, Caregiver, USD

It is published in Valuates Reports under the Medical Devices & Equipment Category.

Key Points: 
  • It is published in Valuates Reports under the Medical Devices & Equipment Category.
  • Due to the COVID-19 pandemic, the global Medical Beds market size is estimated to be worth USD 4315.7 Million in 2022 and is forecast to a readjusted size of USD 5004.9 Million by 2028 with a CAGR of 2.5% during the review period.
  • This rapid growth in the healthcare industry is expected to fuel the growth of the medical bed market.
  • Based on region, with a market share of roughly 31% in 2019 for medical beds, Europe would be the largest region.

GRANDVIEW AVIATION TAKES DELIVERY OF 3 NEW JETS, POISED TO LAUNCH NEW BASES IN TETERBORO & RENO THIS MONTH

Retrieved on: 
Monday, July 11, 2022
GMR, Sikorsky, AMR, LinkedIn, Family, Grandview, RNO, Air Evac Lifeteam, Embraer Phenom 300, Global Medical Aid, VIP, Transport, FAA, American Medical Response, View, Transplant, Embraer, Multimedia, Atmosphere, AirMed International, Aircraft, TEB, Patient, Airline

BALTIMORE, July 11, 2022 /PRNewswire/ -- GrandView Aviation's fleet of Embraer Phenom 300 super light jets grew by three during Quarter 2 for a total of 17 and the company is scheduled to open new bases in Teterboro, MJ (TEB) on July 15 and Reno, NV (RNO) on July 18, bringing the total to 10 U.S. bases coast to coast including locations in Baltimore/DC, Atlanta, Austin, Boston, Chicago, Denver, Los Angeles and Phoenix.

Key Points: 
  • "We are truly living our mission of setting the new standard in private aviation.
  • "The impact of these new aircraft and bases are far-reaching," said Denise Treadwell, president of AirMed International.
  • GrandView Aviation is a private aviation charter operation serving VIP clients and medical transplant transport missions.
  • GrandView Aviation is a FAA Part 135 certificated aircraft operator and carries the elite Wyvern Wingman safety rating.